Micro-Costing Analysis for the Treatment of Atrial Fibrillation: An Economic Evaluation

Author(s)

Maglionico G1, Tacconi E1, Sgarito G2
1Medtronic Italia, Milan, MI, Italy, 2Ospedale Civico di Palermo, Palermo, Palermo, Italy

OBJECTIVES: Catheter ablation procedures for Atrial Fibrillation (AF) can be evaluated regarding the possibility of reducing the length of hospital stay. Considering the cryoablation procedures, the hospitalization setting is still widespread in Italy, despite the numerous evidence supporting the day hospital management. This analysis aims to evaluate the variation in resource consumption for the two different hospital pathways.

METHODS: The analysis was conducted in a Southern Italian hospital by using Activity-Based Costing method. Through clinical and administrative staff interviews, data on patient pathway costs and dedicated staff time (per minute) have been collected. An economic valorization allowed the definition of the total costs for each hospital setting. The center shared the unit costs of drugs, imaging, laboratory exams, consumables, medical procedures, and visits, while non-clinical staff and overhead were quantified through literature (discounted costs).The focus was on patient journey costs and not on devices, drugs, and consumables that were used in equal amounts in both care settings.

RESULTS: The population treated had an age of 56 ± 9 years (25.9% were women); most of the patients (75%) suffered from paroxysmal AF, 25% from persistent AF. No peri-procedural events were observed in any patient. The cost difference between the two hospitalization settings (ordinary with two nights and daytime with one night) was found to be €493.23 for each patient. The main cost driver for the path in ordinary hospitalization was represented by the hospital stay, which showed to be 36% of the total.

CONCLUSIONS: Wider adoption of day-hospital cryoablation AF procedures, following careful patient selection, would lead to patient management costs and resource consumption optimization. It would result in the reduction of the length of stay and freeing up of beds (allowing their reallocation where necessary), reduction of waiting lists, and acceleration of patient access to care.

Conference/Value in Health Info

2023-11, ISPOR Europe 2023, Copenhagen, Denmark

Value in Health, Volume 26, Issue 11, S2 (December 2023)

Code

EE3

Topic

Economic Evaluation, Medical Technologies

Topic Subcategory

Budget Impact Analysis, Cost-comparison, Effectiveness, Utility, Benefit Analysis, Medical Devices

Disease

Cardiovascular Disorders (including MI, Stroke, Circulatory), Medical Devices

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×